Trial Profile
Adjuvant interferon alpha-2b in Chinese patients with high-risk acral malignant melanoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2011
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary) ; Interferon alpha-2b (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 07 Jun 2011 Preliminary results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 07 May 2011 New trial record
- 12 Apr 2011 Results published in the European Journal of Cancer.